+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Postpartum Hemorrhage Treatment Devices Market by Product, Usability, Distribution Channel, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666495
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Postpartum Hemorrhage Treatment Devices Market grew from USD 812.89 million in 2023 to USD 860.94 million in 2024. It is expected to continue growing at a CAGR of 6.25%, reaching USD 1.24 billion by 2030.

The scope of postpartum hemorrhage (PPH) treatment devices encompasses various medical tools and technologies designed to control and stop excessive bleeding after childbirth, a leading cause of maternal mortality. The necessity for such devices is underscored by the critical importance of timely intervention in PPH cases to prevent severe health outcomes or death. These devices are employed by healthcare professionals in hospital settings, maternity wards, and increasingly, in low-resource settings to address PPH efficiently. The most common end-users are hospitals, clinics, ambulatory surgical centers, and sometimes, homecare settings where proper medical supervision exists.

Market growth is influenced by factors such as increasing awareness of maternal health issues, technological advancements in medical devices, and supportive governmental policies. The rising prevalence of PPH, especially in developing countries, drives the market, as there’s heightened focus on improving healthcare infrastructure. Potential opportunities are evident in the expansion of training programs for healthcare providers, enhancing device affordability, and the integration of new technologies such as AI and IoT for better monitoring and management of PPH. Partnerships with NGOs and government bodies in emerging economies can also catalyze market penetration. However, market growth is challenged by limited access and affordability in low-resource settings, a lack of skilled healthcare personnel, and regulatory hurdles related to medical device approval. Furthermore, socio-cultural barriers in some regions may hinder the adoption of these devices.

Innovation can be spurred by designing low-cost, portable, and easy-to-use devices tailored for low-resource settings, or developing automated systems for real-time monitoring of maternal vitals. Emphasizing on improved data collection and analytics can also aid in customizing treatment methods, enhancing outcomes, and fostering market growth. Research should focus on optimizing existing technologies and researching biosensors or minimally invasive devices to permit more efficient and effective management of PPH. Overall, while the PPH treatment device market is poised for growth, strategic approaches are essential to overcome the challenges and harness the potential opportunities effectively.

Understanding Market Dynamics in the Postpartum Hemorrhage Treatment Devices Market

The Postpartum Hemorrhage Treatment Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increase in complications in pregnancy, such as inverted uterus and multiple pregnancies
    • High prevalence of postpartum hemorrhage
    • Ongoing healthcare reforms and initiatives aimed at improving maternal health services
  • Market Restraints
    • High cost of postpartum hemorrhage treatment devices
  • Market Opportunities
    • Technological advancements and launch of new PPH treatment devices
    • Emergence of vacuum-induced hemorrhage control device for postpartum hemorrhage and others
  • Market Challenges
    • Scarcity of trained healthcare providers

Exploring Porter’s Five Forces for the Postpartum Hemorrhage Treatment Devices Market

Porter’s Five Forces framework further strengthens the insights of the Postpartum Hemorrhage Treatment Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Postpartum Hemorrhage Treatment Devices Market

External macro-environmental factors deeply influence the performance of the Postpartum Hemorrhage Treatment Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Postpartum Hemorrhage Treatment Devices Market

The Postpartum Hemorrhage Treatment Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Postpartum Hemorrhage Treatment Devices Market

The Postpartum Hemorrhage Treatment Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Postpartum Hemorrhage Treatment Devices Market

The Postpartum Hemorrhage Treatment Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Postpartum Hemorrhage Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include 3RD Stone Design, Inc., Bactiguard Holding AB, Becton, Dickinson and Company, Cardinal Health, Inc., Cook Medical, Inc., GE HealthCare Technologies, Inc., Laborie Medical Technologies, Inc., Merck & Co., Inc., Organon & Co., Procurenet Limited, Ribbel International Limited, Sinapi Biomedical, Teleflex, Inc., and Utah Medical Products Inc..

Market Segmentation & Coverage

This research report categorizes the Postpartum Hemorrhage Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Non-Pneumatic Anti-Shock Garment
    • Prefilled Injection System
    • Uterine Tamponade Devices
      • Balloon Tamponade
      • Foley Catheter
  • Usability
    • Disposable Devices
    • Reusable Devices
  • Distribution Channel
    • Offline
    • Online
  • Application
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Postpartum Hemorrhage Treatment Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in complications in pregnancy, such as inverted uterus and multiple pregnancies
5.1.1.2. Growth in anemia cases in pregnant women
5.1.1.3. Rising cases of postpartum hemorrhage risk factors and surging awareness regarding them
5.1.2. Restraints
5.1.2.1. High cost of postpartum hemorrhage treatment devices
5.1.3. Opportunities
5.1.3.1. Technological advancements and launch of new PPH treatment devices
5.1.3.2. Emergence of vacuum-induced hemorrhage control device for postpartum hemorrhage and others
5.1.4. Challenges
5.1.4.1. Scarcity of trained healthcare providers
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Postpartum Hemorrhage Treatment Devices Market, by Product
6.1. Introduction
6.2. Non-Pneumatic Anti-Shock Garment
6.3. Prefilled Injection System
6.4. Uterine Tamponade Devices
6.5.1. Balloon Tamponade
6.5.2. Condom Catheter
6.5.3. Foley Catheter
7. Postpartum Hemorrhage Treatment Devices Market, by Application
7.1. Introduction
7.2. Clinics
7.3. Hospitals
8. Americas Postpartum Hemorrhage Treatment Devices Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Postpartum Hemorrhage Treatment Devices Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Postpartum Hemorrhage Treatment Devices Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. 3rd Stone Design, Inc.
12.1.2. Alydia Health
12.1.3. Angiplast Pvt. Ltd.
12.1.4. Bactiguard Holding AB
12.1.5. Becton, Dickinson and Company
12.1.6. Boen Healthcare Co., Ltd.
12.1.7. Clinical Innovations, LLC
12.1.8. Cook Medical, Inc.
12.1.9. General Electric Company
12.1.10. Inpress Technologies Inc.
12.1.11. Obstetrx, Inc.
12.1.12. Organon & Co.
12.1.13. Revmedx Inc.
12.1.14. Sara Health Care
12.1.15. Sterimed Group
12.1.16. Teleflex, Inc.
12.1.17. Utah Medical Products, Inc.
12.1.18. Vitality Medical
12.1.19. Zoex Corporation
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET RESEARCH PROCESS
FIGURE 2. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET DYNAMICS
FIGURE 7. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY NON-PNEUMATIC ANTI-SHOCK GARMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFILLED INJECTION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 10. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BALLOON TAMPONADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY FOLEY CATHETER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 28. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 31. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 45. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 48. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 54. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 72. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 82. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 85. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 88. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 91. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 94. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 100. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 109. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 112. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 115. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 127. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 136. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 144. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 145. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET LICENSE & PRICING

Companies Mentioned

The leading players in the Postpartum Hemorrhage Treatment Devices market, which are profiled in this report, include:
  • 3RD Stone Design, Inc.
  • Bactiguard Holding AB
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Cook Medical, Inc.
  • GE HealthCare Technologies, Inc.
  • Laborie Medical Technologies, Inc.
  • Merck & Co., Inc.
  • Organon & Co.
  • Procurenet Limited
  • Ribbel International Limited
  • Sinapi Biomedical
  • Teleflex, Inc.
  • Utah Medical Products Inc.

Methodology

Loading
LOADING...

Table Information